Esperion Therapeutics
ESPR
#7077
Rank
ยฃ0.26 B
Marketcap
ยฃ1.33
Share price
0.57%
Change (1 day)
33.53%
Change (1 year)

Esperion Therapeutics (ESPR) - Cash on Hand

Cash on Hand as of June 2024 : ยฃ0.14 B

According to Esperion Therapeutics's latest financial reports the company has ยฃ0.14 B in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Esperion Therapeutics - Cash on Hand chart (from 2000 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31ยฃ64.55 M-53.19%
2022-12-31ยฃ0.13 B-28.02%
2021-12-31ยฃ0.19 B-14.22%
2020-12-31ยฃ0.22 B47.65%
2019-12-31ยฃ0.15 B41.92%
2018-12-31ยฃ0.10 B-28.03%
2017-12-31ยฃ0.14 B-13.61%
2016-12-31ยฃ0.17 B19.84%
2015-12-31ยฃ0.14 B110.45%
2014-12-31ยฃ67.98 M86.95%
2013-12-31ยฃ36.36 M803.15%
2012-12-31ยฃ4.02 M298.37%
2011-12-31ยฃ1.01 M
2002-12-31ยฃ27.97 M-42.29%
2001-12-31ยฃ48.47 M3.02%
2000-12-31ยฃ47.05 M1187.77%
1999-12-31ยฃ3.65 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
ยฃ0.58 B 303.49%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.93 B 546.76%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ5.41 B 3,651.11%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ7.47 B 5,081.61%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.19 B 37.38%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.23 B 63.74%๐Ÿ‡บ๐Ÿ‡ธ USA